Molecular Pathways Related to Short-term Fasting Response

计划入组 20 人 · 首次发布于 2020 年 2 月 7 日

A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501

计划入组 28 人 · 首次发布于 2012 年 3 月 8 日

OPEN STUDY RANDOM OF PARALLEL GROUPS AND MULTICENTER OF PHARMACOKINETICS (FAITH) AND PHARMACODYNAMICS (FD) OF AXID (NIZATIDINE) IN PEDIATRIC PATIENTS FROM 5 DAYS TO 12 YEARS OLD WITH SYMPTOMS OF GASTROESOPHAGEAL REFLUX.

计划入组 0 人

WCC-P21

TG01 vaccine

p21 Activated Kinase Program(Turning Point Therapeutics, Inc.)

BIO-21 CENTURY PTY LTD

Australia

Ractigen Therapeutics Secures U.S. FDA IND Clearance for First-in-Class saRNA Therapy RAG-1C Targeting Proliferative Vitreoretinopathy

Signadori Bio Appoints Dr. Selwyn Ho as CEO to Advance Novel Monocyte Immunotherapy Platform

ZetaFuse Demonstrates Bone Fusion in Lung Cancer Patient with Degenerative Disc Disease